Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3053% below fair value
$43.64+0.61 (+1.42%)
Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –
Boston Scientific free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Boston Scientific's free cash flow for the twelve months ending Jun 30, 2026 was $3.63B, up 4.0% year over year. For fiscal 2025 it was $3.66B, up 38.3% from the year before. Over ten years it grew 23.5% a year on average. The highest annual figure on record is $3.66B in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.66B | +38.3% |
| FY2024 | Dec 31, 2024 | $2.65B | +47.6% |
| FY2023 | Dec 31, 2023 | $1.79B | +91.0% |
| FY2022 | Dec 31, 2022 | $938.00M | -28.7% |
| FY2021 | Dec 31, 2021 | $1.32B | +16.3% |
| FY2020 | Dec 31, 2020 | $1.13B | -17.7% |
| FY2019 | Dec 31, 2019 | $1.38B | – |
| FY2018 | Dec 31, 2018 | -$6.00M | -100.5% |
| FY2017 | Dec 31, 2017 | $1.11B | +37.3% |
| FY2016 | Dec 31, 2016 | $806.00M | +81.5% |
| FY2015 | Dec 31, 2015 | $444.00M | -56.0% |
| FY2014 | Dec 31, 2014 | $1.01B | +16.8% |
| FY2013 | Dec 31, 2013 | $865.00M | -17.9% |
| FY2012 | Dec 31, 2012 | $1.05B | +49.7% |
| FY2011 | Dec 31, 2011 | $704.00M | +1228.3% |
| FY2010 | Dec 31, 2010 | $53.00M | -89.9% |
| FY2009 | Dec 31, 2009 | $523.00M | -38.8% |
| FY2008 | Dec 31, 2008 | $854.00M | +49.6% |
| FY2007 | Dec 31, 2007 | $571.00M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.28B | +13.3% |
| Q1 FY2026 | Mar 31, 2026 | $171.00M | -51.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.01B | -14.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.16B | +41.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.13B | +71.6% |
| Q1 FY2025 | Mar 31, 2025 | $354.00M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.18B | +70.9% |
| Q3 FY2024 | Sep 30, 2024 | $823.00M | +62.0% |
| Q2 FY2024 | Jun 30, 2024 | $658.00M | +27.8% |
| Q1 FY2024 | Mar 31, 2024 | -$15.00M | -119.0% |
| Q4 FY2023 | Dec 31, 2023 | $690.00M | +16.0% |
| Q3 FY2023 | Sep 30, 2023 | $508.00M | +58.7% |
| Q2 FY2023 | Jun 30, 2023 | $515.00M | +155.0% |
| Q1 FY2023 | Mar 31, 2023 | $79.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $595.00M | +180.7% |
| Q3 FY2022 | Sep 30, 2022 | $320.00M | -10.6% |
| Q2 FY2022 | Jun 30, 2022 | $202.00M | -62.4% |
| Q1 FY2022 | Mar 31, 2022 | -$179.00M | -185.6% |
| Q4 FY2021 | Dec 31, 2021 | $212.00M | -58.8% |
| Q3 FY2021 | Sep 30, 2021 | $358.00M | -39.7% |
| Q2 FY2021 | Jun 30, 2021 | $537.00M | +167.2% |
| Q1 FY2021 | Mar 31, 2021 | $209.00M | – |
| Q4 FY2020 | Dec 31, 2020 | $514.00M | +1.6% |
| Q3 FY2020 | Sep 30, 2020 | $594.00M | +55.9% |
| Q2 FY2020 | Jun 30, 2020 | $201.00M | 0.0% |
| Q1 FY2020 | Mar 31, 2020 | -$177.00M | -161.7% |
| Q4 FY2019 | Dec 31, 2019 | $506.00M | – |
| Q3 FY2019 | Sep 30, 2019 | $381.00M | -10.4% |
| Q2 FY2019 | Jun 30, 2019 | $201.00M | – |
| Q1 FY2019 | Mar 31, 2019 | $287.00M | +115.8% |
| Q4 FY2018 | Dec 31, 2018 | -$87.00M | -114.4% |
| Q3 FY2018 | Sep 30, 2018 | $425.00M | +8.4% |
| Q2 FY2018 | Jun 30, 2018 | -$477.00M | -308.3% |
| Q1 FY2018 | Mar 31, 2018 | $133.00M | – |
| Q4 FY2017 | Dec 31, 2017 | $605.00M | +18.9% |
| Q3 FY2017 | Sep 30, 2017 | $392.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $229.00M | – |
| Q1 FY2017 | Mar 31, 2017 | -$119.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $509.00M | – |
| Q3 FY2016 | Sep 30, 2016 | -$102.00M | – |
See a number that looks wrong?